Altimmune said on Thursday its experimental obesity drug met the main goal of a mid-stage trial studying it as a potential treatment for a fatty liver disease.

A bogged-down liver could be to blame. Burning fat, filtering toxins and keeping blood sugar and cholesterol in healthy ...

Fatty liver disease, increasingly prevalent among young individuals, stems from unhealthy diets, sedentary lifestyles, and ...

Altimmune shares rose 13% in premarket trading following an announcement it would present topline 24-week data from its Phase 2b trial evaluating pemvidutide as a treatment for those with metabolic ...

Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of cancer-related deaths ...

ABC News' Dr. Tara Narula breaks down the condition affecting nearly one in four Americans and the promising treatment giving patients new hope.

This new review article highlights the critical role of ribosome biogenesis in liver health and disease progression.

Discover a study that found that individuals with higher baseline IL-1β levels experienced greater improvements in liver ...

The European Union's drug regulator on Friday recommended conditional authorisation of Madrigal Pharmaceuticals' Rezdiffra, ...

This study, published in the American Journal of Pathology, also reminds us of the serious health risks of long-term heavy ...

Elevidys has been given full approval to treat ambulatory patients with DMD, with an accelerated approval in non-ambulatory ...

In a remarkable scientific breakthrough, researchers have discovered a rare autoinflammatory disease called Lyn ...